8-K

CRH PUBLIC LTD CO 8-K Report (Sep 8, 2023)

Filed September 8, 2023For Securities:CRH

Summary

CRH Public Limited Company (CRH) filed a Form 6-K on September 7, 2023, reporting a transaction by a key executive. Specifically, Neil Colgan, the Company Secretary, exercised options under the CRH Savings-related Share Option Scheme. This transaction involved 1,293 ordinary shares of €0.32 each, with the options exercised at a price of €23.39 per share on September 6, 2023, in Dublin, Ireland. This filing is important for investors as it provides transparency regarding insider transactions. While exercising options can be a normal part of executive compensation, it signals the executive's confidence in the company's valuation at the exercise price. Investors should note this transaction as part of their broader analysis of insider activity and management's stake in the company's performance.

Key Highlights

  • 1Reporting of a transaction by a Person Discharging Managerial Responsibilities (PDMR).
  • 2Neil Colgan, Company Secretary of CRH plc, is the PDMR involved.
  • 3The transaction involves the exercise of options under CRH's Savings-related Share Option Scheme.
  • 41,293 ordinary shares were exercised at a price of €23.39 per share.
  • 5The transaction date was September 6, 2023.
  • 6The transaction took place in Dublin, Ireland.
  • 7The filing is a requirement under the EU Market Abuse Regulation (MAR).

Frequently Asked Questions

Neil Colgan, the Company Secretary, exercised options granted to him under CRH's Savings-related Share Option Scheme.

The transaction involved 1,293 ordinary shares of €0.32 each, with the options exercised at a price of €23.39 per share.

This filing provides transparency into insider transactions. It shows a key executive exercising share options, which can be interpreted in various ways regarding their belief in the company's current valuation and future prospects.

This specific filing reports the exercise of options, meaning the executive acquired the shares by paying the exercise price. It does not indicate whether these acquired shares were subsequently sold.